
About Sanquin
Sanquin is a Government & Social Sector company based in Amsterdam (Netherlands) founded in 1998. Foundation focused on blood collection and supply. Its chief executive, as recorded, is Ivo N. van Schaik. Sanquin offers products and services including Blood Products and Diagnostic Services. Its focus areas include Healthcare and Healthcare Foundations.
Company details
Sanquin was established in 1998 in Amsterdam, Netherlands, as a foundation in the healthcare sector specializing in blood services. Donors are recruited, and blood is processed into products including red blood cells, platelets, and plasma for direct delivery to hospitals. Research efforts are directed toward transfusion medicine, hematology, immunology, and cell therapy, with partnerships formed alongside national and international academic institutions.
- Headquarters Amsterdam, Netherlands
- SectorsGovernment & Social Sector
- Phoneβ’β’β’β’ β’β’β’β’
- Website sanquin.org
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Sanquin
- Latest Funding Round$206.64K (USD), Grant
Sep 2022
- InvestorsHHS
& 1 more
Products & Services of Sanquin
Sanquin offers a comprehensive portfolio of products and services, including Blood Products and Diagnostic Services.
Blood products are supplied for transfusion and therapeutic purposes in healthcare settings.
Diagnostic services are provided for tests like non-invasive fetal blood group genotyping and next-generation sequencing.
Apps and channels of Sanquin
its YouTube channel Sanquin has 2.47K subscribers and 30 videos.
Videos from Sanquin
The most watched videos on Sanquin's YouTube channel, Sanquin (2.47K subscribers). Click a video to play it here.
More on Sanquin.
Funding Insights of Sanquin
- Total Rounds 12
- Last Round Grant β $206,638
- First Round $1.7M
(Jul 2008)
- Investors Count 2
Latest 10 of 12 funding rounds of Sanquin with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $206,638 | Grant | β | β | |
| Jul 2020 | $491,635 | Grant | β | β | |
| Apr 2020 | $305,477 | Grant | β | β | |
| Jan 2020 | $938,695 | Grant | β | β | |
| Mar 2019 | $2.28M | Grant | β | β | |
| May 2018 | $298,796 | Grant | β | β | |
| Jan 2018 | $1.09M | Grant | β | β | |
| Sep 2017 | $197,633 | Grant | β | β | |
| Oct 2015 | $571,615 | Grant | β | β | |
| Sep 2015 | $576,789 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in Sanquin
Sanquin has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Sanquin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sanquin
1 people are tracked at Sanquin (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ivo N. van Schaik | CEO | Leadership |
Complete people profiles for Sanquin
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sanquin
3 dated milestones of Sanquin across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Sanquin is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Grant, of $207K.
Web traffic of Sanquin
The website of Sanquin (sanquin.org) receives about 9.3K visits a month.
- Monthly visits9.3K
▼ 14.4% vs previous month
Websites whose visitors overlap most with Sanquin. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ifmsa.nl | ifmsa.nl | 100% | #2,526,883 | β | |
slingeland.nl | slingeland.nl | 93% | #162,230 | β | |
nspoh.nl | nspoh.nl | 88% | #463,441 | β | |
reuma.nl | reuma.nl | 83% | #590,987 | β | |
| europeanbloodalliance.eu | 76% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 25 similar websites and full traffic analytics for Sanquin
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sanquin
Sanquin was founded in 1998 and raised its 1st funding round 10 years after it was founded.
Sanquin is headquartered in Amsterdam, Netherlands.
Ivo N. van Schaik is the CEO of Sanquin, as recorded in our data.
Sanquin was established in 1998 in Amsterdam, Netherlands, as a foundation in the healthcare sector specializing in blood services. Donors are recruited, and blood is processed into products including red blood cells, platelets, and plasma for direct delivery to hospitals. Research efforts are directed toward transfusion medicine, hematology, immunology, and cell therapy, with partnerships formed alongside national and international academic institutions.
Sanquin offers Blood Products and Diagnostic Services.
Sanquin has 2 investors. Key investors include HHS, and European Union.
Sanquin operates through Sanquin.